Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Immix Biopharma, Inc. (IMMX) Institutional Ownership & Insider Trading

109 institutions reported holding Immix Biopharma, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 2 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

IMMXImmix Biopharma, Inc.Follow IMMX — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
583.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

109 institutions held 78.6% of the shares. Across filers that reported both quarters, shares held changed +110.1%.

Increased+34New+42Decreased-13Closed-11

Largest moves, shares (millions)

State Street+2.8MDeep Track Capital+2.8MBlackRock+2.5MSusquehanna International…-0.4MLogos Global Management-0.2MBlue Owl Capital Holdings-0.1M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-0.4Sep 24-1.2Dec 24+0.1Mar 25-0.7Jun 25+0.4Sep 25+21.3Dec 25+1.8Mar 26+24.1Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2610956+110.1%34421311
Mar 267727+7.6%28211312
Dec 256724+771.2%173865
Sep 25313+18.7%71144
Jun 25232-22.5%4544
Mar 25223+2.5%4384
Dec 24233-37.6%2447
Sep 24254-8.8%5056

Immix Biopharma, Inc. — questions

Who owns Immix Biopharma, Inc. stock?
109 institutions reported Immix Biopharma, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Jupiter Topco LLC (13.7%), Saturn V Capital Management LP (6.5%), EVENTIDE ASSET MANAGEMENT, LLC (5.4%).
Are Immix Biopharma, Inc. insiders buying or selling?
2 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Immix Biopharma, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.